Method for treating cognitive dysfunction
AssigneeEli Lilly and Company
InventorCHARLES M BEASLEY JR
Life of this patent
Estimating the term…
Abstract
The invention provides a method for treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
Claims16
A method for treating a cognitive dysfunction comprising administering to a mammal in need of such treatment, an effective amount 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine, or a pharmaceutically acceptable salt thereof.
A method for palliatively treating a cognitive dysfunction comprising administering to a mammal in need of such treatment, an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.